Addressing challenges with Matching-Adjusted Indirect Comparisons to demonstrate the comparative effectiveness of entrectinib in metastatic ROS-1 positive Non-Small Cell Lung Cancer. - Esnault C; Baschet L; Barbet V; Chenuc G; Pérol M; Thokagevistk K; Pau D; Monnereau M; Bosquet L; Filleron T (BMC medical research methodology, 2025)